课题基金 / 基金详情

Analysis of JET1 mutant, which does not require CDK activity in the initiation of DNA replication

Analysis of JET1 mutant, which does not require CDK activity in the initiation of DNA replication
JET1 突变体的分析,该突变体在 DNA 复制启动时不需要 CDK 活性
批准号:
18570167
负责人:
TANAKA Seiji
金额:
$2.63万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2006
资助国家:
日本
项目状态:
已结题
起止时间:
2006 至 2007

项目摘要

项目成果

TANAKA Seiji的其他基金

相似基金

相关文献

中文摘要
翻译
真核生物的DNA复制起始于多个复制起点,它们被CDK和CDC7-Dbf4两种蛋白激酶激活,DNA复制起始于S期。CDK在这一过程中的底物长期未知,S1d2在2002年的启动中被认为是CDK的一个重要靶点。我已经证明,SLD2的磷酸化是必要的,但不是启动所必需的。因此,为了识别未知的CDK靶点,我建立了基因筛查。在筛选过程中,构建了S1d2的拟磷突变体(S1d2-D),并分离到了新的突变体JET1,该突变体即使在没有CDK活性的情况下也能与S1d2-D一起启动DNA复制。该JET1突变发生在CDC45中,这是启动和延伸所必需的。我们揭示了CDC45不是CDK的底物,而是CDC45的结合伙伴SLD3是CDK启动的主要靶点。我们还表明,SLD2和SLD3的磷酸化增强了Dpb11的相互作用。推测这一反应触发了DNA复制的启动。此外,通过结合绕过sld2和s1d3磷酸化的突变,我们可以绕过启动CDK的要求。这些数据有力地表明,SID2和SLD3在启动过程中构成了CDK的最低基本要求。这些发现对于理解真核细胞DNA复制的启动反应是至关重要的。
英文摘要
Eukaryotic DNA replication initiates from multiple origins of replication They are activated by two protein kinases, CDK and Cdc7-Dbf4, and DNA replication initiates in S phase. Substrates of CDK in this process was unknown for long time, S1d2 was shown as an essential target of CDK in the initiation in 2002. I have shown that Sld2 phosphorylation is necessary but not essential for the initiation. Therefore, to identify unknown CDK target, I set up a genetic screening. In the screening, phosphomimetic mutant of Sld2 (S1d2-D) was constructed and isolated the novel mutant JET1, which initiated DNA replication in conjunction with S1d2-D even in the absence of CDK activity. This JET1 mutation was occurred in CDC45, which required for the initiation and elongation. We revealed that Cdc45 is not the substrate of CDK, instead Sld3, the binding partner of Cdc45, is the essential target of CDK in initiation. We also showed that phosphorylations of Sld2 and Sld3 enhance the interaction Dpb11. It was suggested that this reaction triggers the initiation of DNA replication. Moreover by combining the mutations that bypass the phosphorylation of Sld2 and S1d3, we could bypass CDK requirements for initiation. These data strongly suggest that Sid2 and Sld3 constitute minimal essential requirements of CDK in initiation. These findings are crucial to understand the initiation reaction of eukaryotic DNA replication.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1186/1747-1028-2-16
发表时间: 2007-06-05
期刊: Cell division
影响因子: 2.3
作者: [Tanaka S, Tak YS, Araki H]
通讯作者: Araki H
CDK-dependent initiation of chromosomal DNA replication in budding yeast
芽殖酵母中 CDK 依赖性染色体 DNA 复制起始
DOI: --
发表时间: 2008
期刊:
影响因子: --
作者: [Matsushita, Y., Furukawa, T., Kasanuki, H., Nishibatake, M., Kurihara, Y., Ikeda, A., Kamatani, N., Takeshima, H., Matsuoka, R., 寺崎哲也, Araki H]
通讯作者: Araki H
CDKによる染色体DNA複製開始の制御機構
CDKs启动染色体DNA复制的控制机制
DOI: --
发表时间: 2006
期刊:
影响因子: --
作者: [Seiji Tanaka, Toshiko Umemori, Kazuyuki Hirai, Sachiko Muramatsu, Yoichiro Kamimura, Hiroyuki Araki, 田中 誠司]
通讯作者: 田中 誠司
CDK-mediated regulation of chromosomal DNA replication in budding yeast
CDK介导的芽殖酵母染色体DNA复制调节
DOI: --
发表时间: 2006
期刊:
影响因子: --
作者: [A. Saito, Y. Muro, K. Sugiura, M. Ikeno. K. Yoda. and Y. Tomita, 竹島 浩, Araki H]
通讯作者: Araki H
21
    Empirical Study on Health Education in Postwar Reconstruction Japan
    • 批准号:
      16K17384
    • 项目类别:
      Grant-in-Aid for Young Scientists (B)
    • 资助金额:
      $1.75万
    • 财政年份:
      2016
    • 负责人:
      TANAKA Seiji
    • 依托单位:
    Prevention of Infectious Diseases in Schools in Occupied Japan
    • 批准号:
      24700721
    • 项目类别:
      Grant-in-Aid for Young Scientists (B)
    • 资助金额:
      $1.75万
    • 财政年份:
      2012
    • 负责人:
      TANAKA Seiji
    • 依托单位:
    The Financial System of the Hagi-Han and the price fluctuation in the last fifty years of Early Modern Japanese History
    • 批准号:
      23520816
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.66万
    • 财政年份:
      2011
    • 负责人:
      TANAKA Seiji
    • 依托单位:
    Phase polyphenism in locusts: factors inducing gregarization
    国内基金
    海外基金
    细胞周期蛋白A2(CCNA2)通过CDK2促进三阴性乳腺癌的增殖及迁移
    • 批准号:
      JCZRLH202601137
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
    • 依托单位:
    抗LAG3抗体改善免疫微环境逆转CDK4/6抑制剂 耐药的机制研究
    • 批准号:
      JCZRLH202600287
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
    • 依托单位:
    姜黄素脂质体协同CDK4/6抑制剂通过ROS/DNA损伤通路阻遏乳腺癌转移的机制研究
    环状RNAcircWEE1通过miR-942介导的IGF1和CDK6通路双重调控骨肉瘤顺铂耐药的作用机制研究